WCM Investment Management
ACAD icon

WCM Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

WCM Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-286,527
Closed -$4.5M – 289
2024
Q3 		$4.5M Sell
286,527
-2,890
-1% -$48.2K 0.01% 169
2024
Q2 		$4.74M Buy
289,417
+7,382
+3% +$119K 0.01% 164
2024
Q1 		$5.21M Buy
+282,035
New +$6.99M 0.01% 160
2021
Q2 		– Sell
-129,864
Closed -$3.35M – 196
2021
Q1 		$3.35M Buy
129,864
+56,330
+77% +$2.48M 0.01% 145
2020
Q4 		$3.93M Buy
73,534
+415
+0.6% +$20.6K 0.01% 148
2020
Q3 		$3.02M Buy
73,119
+3,349
+5% +$145K 0.01% 150
2020
Q2 		$3.38M Sell
69,770
-27,891
-29% -$1.34M 0.01% 143
2020
Q1 		$4.13M Buy
97,661
+28,235
+41% +$1.16M 0.02% 120
2019
Q4 		$2.97M Buy
69,426
+56,750
+448% +$2.47M 0.02% 137
2019
Q3 		$456K Buy
+12,676
New +$384K ﹤0.01% 144

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return